RxDoctor Payments Data

Arianne Kourosh, MD

Dermatology · Boston, MANPI 1417181801

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $74,107 of the $85,366 with a category attached, or 86.8%. AbbVie accounts for 72.5% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $72,646, more than ten times the $5,469 reported in 2019. Among dermatology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$85,366in general payments, 2019–2025

Across 86 payments — averaging $992.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$62K
  • Regeneron$11K
  • Sanofi$7K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$5K
  • Amneal Pharmaceuticals LLC$483
  • Hikma Pharmaceuticals USA$38

What the payments were for

  • Consulting fees$74,10787%
  • Travel & lodging$9,60011%
  • Food & beverage$1,5872%
  • Education$480%
  • Gifts$240%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$85,366 in reported general payments places this provider in the 90th percentile of 552 dermatology providers in Massachusetts.

See all dermatology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$25,686
Medicare patients
170
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole125$2,573
Triamcinolone Acetonide72$1,108
Metronidazole31$1,023
Nystatin34$883
Tretinoin11$733
ValacyclovirValacyclovir Hcl21$683
Clobetasol Propionate12$482
Fluocinonide16$417
Ammonium Lactate14$241
Mupirocin12$50

Paid to pharmacies, not to this prescriber.

Other dermatology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →